You are here

Publications

Found 232 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is N  [Clear All Filters]
2008
Forslund A, Zeng Z, Qin L-X, Rosenberg S, Ndubuisi MK, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB.  2008.  MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.. Mol Cancer Res. 6(2):205-11.
Forslund A, Zeng Z, Qin L-X, Rosenberg S, Ndubuisi MK, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB.  2008.  MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.. Mol Cancer Res. 6(2):205-11.
Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S.  2008.  A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis.. Nat Med. 14(8):849-54.
Merckx A, Nivez M-P, Bouyer G, Alano P, Langsley G, Deitsch K, Thomas S, Doerig C, Egée S.  2008.  Plasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductance.. PLoS Pathog. 4(2):e19.
Bryk R, Gold B, Venugopal A, Singh J, Samy R, Pupek K, Cao H, Popescu C, Gurney M, Hotha S et al..  2008.  Selective killing of nonreplicating mycobacteria.. Cell Host Microbe. 3(3):137-45.
Bacolod MD, Schemmann GS, Wang S, Shattock R, Giardina SF, Zeng Z, Shia J, Stengel RF, Gerry N, Hoh J et al..  2008.  The signatures of autozygosity among patients with colorectal cancer.. Cancer Res. 68(8):2610-21.
2007
Nathan C.  2007.  Aligning pharmaceutical innovation with medical need.. Nat Med. 13(3):304-8.
Park-Min K-H, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB.  2007.  FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.. Immunity. 26(1):67-78.
Park-Min K-H, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB.  2007.  FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.. Immunity. 26(1):67-78.
Nociari M, Ocheretina O, Schoggins JW, Falck-Pedersen E.  2007.  Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator.. J Virol. 81(8):4145-57.
2006
Cohn EF, Nathan C, Radzioch D, Yu H, Xiang Z, Ding A.  2006.  Abrupt expression of TLR4 in TLR4-deficient macrophages imposes a selective disadvantage: genetic evidence for TLR4-dependent responses to endogenous, nonmicrobial stimuli.. J Immunol. 176(2):1185-94.
Vandal OH, Gelb MH, Ehrt S, Nathan CF.  2006.  Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow-derived macrophages for the control of Mycobacterium tuberculosis in vitro.. Infect Immun. 74(3):1751-6.
Cheng Y-W, Shawber C, Notterman D, Paty P, Barany F.  2006.  Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.. Genome Res. 16(2):282-9.
Nathan C.  2006.  Neutrophils and immunity: challenges and opportunities.. Nat Rev Immunol. 6(3):173-82.
Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F et al..  2006.  Relationship of gene expression and chromosomal abnormalities in colorectal cancer.. Cancer Res. 66(4):2129-37.
2005
Morris RP, Nguyen L, Gatfield J, Visconti K, Nguyen K, Schnappinger D, Ehrt S, Liu Y, Heifets L, Pieters J et al..  2005.  Ancestral antibiotic resistance in Mycobacterium tuberculosis.. Proc Natl Acad Sci U S A. 102(34):12200-5.
Morris RP, Nguyen L, Gatfield J, Visconti K, Nguyen K, Schnappinger D, Ehrt S, Liu Y, Heifets L, Pieters J et al..  2005.  Ancestral antibiotic resistance in Mycobacterium tuberculosis.. Proc Natl Acad Sci U S A. 102(34):12200-5.
Shimosato T, Kitazawa H, Katoh S, Tohno M, Iliev ID, Nagasawa C, Kimura T, Kawai Y, Saito T.  2005.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.. Biochem Biophys Res Commun. 326(4):782-7.
Hisert KB, MacCoss M, Shiloh MU, K Darwin H, Singh S, Jones RA, Ehrt S, Zhang Z, Gaffney BL, Gandotra S et al..  2005.  A glutamate-alanine-leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic diGMP.. Mol Microbiol. 56(5):1234-45.
Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E.  2005.  Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.. J Virol. 79(18):11627-37.
Nathan C, Calingasan N, Nezezon J, Ding A, M Lucia S, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NSoo et al..  2005.  Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.. J Exp Med. 202(9):1163-9.
Nathan C, Calingasan N, Nezezon J, Ding A, M Lucia S, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NSoo et al..  2005.  Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.. J Exp Med. 202(9):1163-9.
Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang X-Y.  2005.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.. Proc Natl Acad Sci U S A. 102(10):3772-6.
2004
Philpott NJ, Nociari M, Elkon KB, Falck-Pedersen E.  2004.  Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.. Proc Natl Acad Sci U S A. 101(16):6200-5.
Nathan C.  2004.  Antibiotics at the crossroads.. Nature. 431(7011):899-902.